CD11c: Difference between revisions
From haematologyetc.co.uk
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
:An adhesion molecule whose expression is confined to leukocytes. High levels of expression are particularly useful in two ontexts: | :An adhesion molecule whose expression is confined to leukocytes. High levels of expression are particularly useful in two ontexts: | ||
:Contributing to the | :Contributing to the identifyication of monocytic differentiation in myeloid disorders | ||
:Contributing to the idenfification hairy cell leukaemia or related disorders in lymphoid diagnosis, though care must be taken since expression is not fully specific to these disorders. | :Contributing to the idenfification hairy cell leukaemia or related disorders in lymphoid diagnosis, though care must be taken since expression is not fully specific to these disorders. | ||
Revision as of 09:28, 1 May 2023
- Summary
- An adhesion molecule whose expression is confined to leukocytes. High levels of expression are particularly useful in two ontexts:
- Contributing to the identifyication of monocytic differentiation in myeloid disorders
- Contributing to the idenfification hairy cell leukaemia or related disorders in lymphoid diagnosis, though care must be taken since expression is not fully specific to these disorders.
Normal expression and function
xxxxx
Diagnostic role
- xxxxx
Other relevant information:
xxxxx
SUMMARY TABLES
| Expression in primitive cell types | ||||||
|---|---|---|---|---|---|---|
| AML | B ALL | Burkitt | T ALL | ETP ALL (i) | MPAL i | Hgns i |
| ? <5% 5-20% 20-40% 40-80% 80-100% | ? <5% 5-20% 20-40% 40-80% 80-100% | ? <5% 5-20% 20-40% 40-80% 80-100% | ? <5% 5-20% 20-40% 40-80% 80-100% | ? <5% 5-20% 20-40% 40-80% 80-100% | ? <5% 5-20% 20-40% 40-80% 80-100% | ? <5% 5-20% 20-40% 40-80% 80-100% |
Notes: xxxxx
| CD13 expression: mature B cell neoplasms | |||||||
|---|---|---|---|---|---|---|---|
| CLL | MCL | FL | MZL | HCL | DLBCL | LPL | PCL |
| ? <5% 5-20% 20-40% 40-80% 80-100% | ? <5% 5-20% 20-40% 40-80% 80-100% | ? <5% 5-20% 20-40% 40-80% 80-100% | ? <5% 5-20% 20-40% 40-80% 80-100% | ? <5% 5-20% 20-40% 40-80% 80-100% | ? <5% 5-20% 20-40% 40-80% 80-100% | ? <5% 5-20% 20-40% 40-80% 80-100% | ? <5% 5-20% 20-40% 40-80% 80-100% |
Notes: xxxxx
| Expression in mature T cell neoplasms* | ||||||
|---|---|---|---|---|---|---|
| ATLL | CTCL/Sezary | T-PLL | T-LGL | NK-LGL | ||
| ? <5% 5-20% 20-40% 40-80% 80-100% | ? <5% 5-20% 20-40% 40-80% 80-100% | ? <5% 5-20% 20-40% 40-80% 80-100% | ? <5% 5-20% 20-40% 40-80% 80-100% | ? <5% 5-20% 20-40% 40-80% 80-100% | ||
Notes: xxxxx